Holmusk
Overview
Data science company behind NeuroBlu, the largest NLP-enriched behavioral health and neurology real-world database, with over 46 million de-identified patient lives from longitudinal EHR data. Serves biopharma with analytics for evidence generation in psychiatry and neurodegenerative disease.
Notable
Expanded NeuroBlu to 46 million patients in 2026, adding neurology depth and biomarker data; founded in Singapore with US headquarters in New York.
Key services
- NeuroBlu behavioral health RWD platform
- NLP extraction from psychiatric clinical notes
- cohort discovery and outcomes analytics
- RWE studies in mental health and neurology
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of Holmusk? Share your experience in a short, confidential interview.
Share your experience